PEP delayed until Q4 (page 3 yellow banner), and looks like sales won't be progressing until late Q4, rather than early Q4 like previously stated. If I'm understanding it all correctly, no big surprises, and kick the can down the road just a little bit more while they get everything set up.
Launch Meeting late Jan, but looking like a 1M size group targeted from December, so sales are unlikely to be overwhelming for Q4 results. I guess if 5% of 1 Mil - its 50k prescriptions will be a good start.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.025(7.69%) |
Mkt cap ! $588.2M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 30.0¢ | $3.064M | 9.775M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 449742 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |